Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 24Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Church & Dwight Co

02 1DELCOR ASSET

03 1Grupo Columbia

04 4Guardian Drug Company

05 3Juno Pharmaceuticals Pty Ltd

06 1Laboratorios Imperiales, S.A. de C.V.

07 1Nostrum Laboratories

08 6PROCTER AND GAMBLE

09 1Suncare Formulations

10 2Vista Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : GASTROVOL LIQUID GELS

Dosage Form : CAPSULE

Dosage Strength : 262MG

Packaging :

Approval Date :

Application Number : 2534436

Regulatory Info : OTC

Registration Country : Canada

blank

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE

Brand Name : HELIDAC

Dosage Form : TABLET, CHEWABLE, TABLET, CAPSULE;ORAL

Dosage Strength : 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1996-08-15

Application Number : 50719

Regulatory Info : DISCN

Registration Country : USA

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Bismuth Subsalicylate; Ranitidine Hydrochloride

Brand Name : Peptimax

Dosage Form : Tablet

Dosage Strength : 131.5MG; 12.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country :

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : BISMUTH SUBSALICYLATE CAPLETS

Dosage Form : TABLET

Dosage Strength : 262MG

Packaging : 24

Approval Date :

Application Number : 2326582

Regulatory Info : OTC

Registration Country : Canada

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : BISMUTH SUBSALICYLATE SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 17.5MG/ML

Packaging : 230ML/480ML

Approval Date :

Application Number : 2313162

Regulatory Info : OTC

Registration Country : Canada

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 35MG/ML

Packaging : 236/350/473ML

Approval Date :

Application Number : 2328453

Regulatory Info : OTC

Registration Country : Canada

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : STOMACH RELIEF CHEWABLE TABLETS

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 262MG

Packaging : 24/48

Approval Date :

Application Number : 2389215

Regulatory Info : OTC

Registration Country : Canada

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : EXTRA STRENGTH BISMUTH

Dosage Form : SUSPENSION

Dosage Strength : 35.2MG/ML

Packaging : 350ML

Approval Date :

Application Number : 2475855

Regulatory Info : OTC

Registration Country : Canada

blank

09

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : REGULAR STRENGTH BISMUTH

Dosage Form : SUSPENSION

Dosage Strength : 17.5MG/ML

Packaging : 115/230/236/350/480ML

Approval Date :

Application Number : 2468646

Regulatory Info : OTC

Registration Country : Canada

blank

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : BISMUTH CAPLETS

Dosage Form : TABLET

Dosage Strength : 262MG

Packaging : 24

Approval Date :

Application Number : 2457121

Regulatory Info : OTC

Registration Country : Canada

blank

11

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Bismuth Subsalicylate; sodium bicarbonata; Aluminium hydroxychloride

Brand Name : Estomacurol®

Dosage Form : ; ;

Dosage Strength : ; ;

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Mexico

blank

12

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE

Brand Name : BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE

Dosage Form : TABLET, CHEWABLE, TABLET, CAPSULE;ORAL

Dosage Strength : 262.4MG, N/A, N/A;N/A, 250MG, N/A;N/A, N/A, 500MG

Packaging :

Approval Date : 2018-11-30

Application Number : 202584

Regulatory Info : RX

Registration Country : USA

blank

13

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : PEPTO BISMOL CAPLET - 262MG/CAPLET

Dosage Form : TABLET

Dosage Strength : 262MG

Packaging : 24 CAPLETS

Approval Date :

Application Number : 2177994

Regulatory Info : OTC

Registration Country : Canada

blank

14

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : PEPTO-BISMOL

Dosage Form : SUSPENSION

Dosage Strength : 17.6MG/ML

Packaging : 115/230/350/480ML

Approval Date :

Application Number : 2097079

Regulatory Info : OTC

Registration Country : Canada

blank

15

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : PEPTO-BISMOL EXTRA

Dosage Form : SUSPENSION

Dosage Strength : 35.2MG/ML

Packaging : 350ML

Approval Date :

Application Number : 2229668

Regulatory Info : OTC

Registration Country : Canada

blank

16

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : PEPTO-BISMOL CHEWABLES

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 262MG

Packaging : 12/24/48

Approval Date :

Application Number : 2237315

Regulatory Info : OTC

Registration Country : Canada

blank

17

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : PEPTO BISMOL LIQUICAPS

Dosage Form : CAPSULE

Dosage Strength : 262MG

Packaging :

Approval Date :

Application Number : 2499991

Regulatory Info : OTC

Registration Country : Canada

blank

18

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

BISMUTH SUBSALICYLATE

Brand Name : PEPTO-BISMOL EXTRA CAPLET

Dosage Form : TABLET

Dosage Strength : 524MG/TAB

Packaging :

Approval Date :

Application Number : 2530759

Regulatory Info : OTC

Registration Country : Canada

blank

19

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Bismuth Subsalicylate

Brand Name :

Dosage Form : Oral Suspension

Dosage Strength : 525MG/15ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

20

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Bismuth Subsalicylate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 262MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

21

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Bismuth Subsalicylate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 324MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank